Arnold S. Bayer

Active 1976–2024

144
Papers
32,214
Citations
92
h-index
139
i10-index

Citations

Citations per year for Arnold S. Bayer1936: 1 citations1977: 3 citations1978: 9 citations1979: 4 citations1980: 5 citations1981: 6 citations1982: 5 citations1983: 13 citations1984: 10 citations1985: 10 citations1986: 11 citations1987: 9 citations1988: 9 citations1989: 11 citations1990: 8 citations1991: 8 citations1992: 16 citations1993: 13 citations1994: 25 citations1995: 23 citations1996: 32 citations1997: 53 citations1998: 57 citations1999: 80 citations2000: 98 citations2001: 80 citations2002: 114 citations2003: 123 citations2004: 128 citations2005: 174 citations2006: 209 citations2007: 190 citations2008: 219 citations2009: 251 citations2010: 222 citations2011: 328 citations2012: 318 citations2013: 317 citations2014: 307 citations2015: 338 citations2016: 294 citations2017: 207 citations2018: 185 citations2019: 893 citations2020: 811 citations2021: 655 citations2022: 511 citations2023: 370 citations2024: 707 citations2025: 284 citations2026: 4 citations1937–1976: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,658 citing papers, 32.9% of this breakdownUnited Kingdom: 440 citing papers, 5.4% of this breakdownGermany: 437 citing papers, 5.4% of this breakdownChina: 420 citing papers, 5.2% of this breakdownFrance: 375 citing papers, 4.6% of this breakdownCanada: 305 citing papers, 3.8% of this breakdownItaly: 295 citing papers, 3.7% of this breakdownSpain: 286 citing papers, 3.5% of this breakdownAustralia: 243 citing papers, 3% of this breakdownSwitzerland: 176 citing papers, 2.2% of this breakdownNetherlands: 170 citing papers, 2.1% of this breakdownIndia: 165 citing papers, 2% of this breakdown
0%32.9%Other 26.2%

Fields

  • Medicine67.9%
  • Biochemistry, Genetics and Molecular Biology13.9%
  • Immunology and Microbiology10%
  • Agricultural and Biological Sciences1.9%
  • Environmental Science1.9%
  • Health Professions0.9%
  • Other3.5%

Topics

  • Antimicrobial Resistance in Staphylococcus15.4%
  • Infective Endocarditis Diagnosis and Management7.9%
  • Bacterial biofilms and quorum sensing6.1%
  • Bacterial Identification and Susceptibility Testing5.1%
  • Streptococcal Infections and Treatments5.1%
  • Antimicrobial Peptides and Activities4%
  • Other56.4%

Coauthors

All papers

Open in search
  1. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

    Authors: , , , , , , , , , , , , , , , - Circulation 2015 cited by 3,171

  2. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

    Authors: , , , , , , , , , , , , - Clinical Infectious Diseases 2011 cited by 4,179

  3. The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2023 cited by 720

  4. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

    Authors: , , , , , , , , , , , , - Clinical Infectious Diseases 2011 cited by 1,599

  5. The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion

    Authors: , , , , , , , , - PLoS Pathogens 2009 cited by 361

  6. Mechanism of Action and Resistance to Daptomycin inStaphylococcus aureusand Enterococci

    Authors: , , - Cold Spring Harbor Perspectives in Medicine 2016 cited by 230

  7. Infective endocarditis

    Authors: , , , , , - Nature Reviews Disease Primers 2016 cited by 397

  8. New Mechanistic Insights into Purine Biosynthesis with Second Messenger c-di-AMP in Relation to Biofilm-Related Persistent Methicillin-Resistant Staphylococcus aureus Infections

    Authors: , , , , , , , , , - mBio 2021 cited by 49

  9. Daptomycin-Resistant Enterococcus faecalis Diverts the Antibiotic Molecule from the Division Septum and Remodels Cell Membrane Phospholipids

    Authors: , , , , , , , , , , , , , - mBio 2013 cited by 196

  10. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance

    Authors: , , , , , , , , - mBio 2018 cited by 102

  11. Staphylococcus aureus Endocarditis

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA 2005 cited by 1,168

  12. Infective Endocarditis

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2005 cited by 1,701

  13. Advances in antimicrobial peptide immunobiology

    Authors: , , , - Biopolymers 2006 cited by 277

  14. Daptomycin Resistance in Enterococci Is Associated with Distinct Alterations of Cell Membrane Phospholipid Content

    Authors: , , , , , , , - PLoS ONE 2012 cited by 165

  15. Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall

    Authors: , , - Annals of the New York Academy of Sciences 2012 cited by 311

  16. Persistent methicillin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management

    Authors: , , - Clinical Infectious Diseases 2022 cited by 46

  17. External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis

    Authors: , , , , , , , , , , , , , - Clinical Infectious Diseases 2024 cited by 42

  18. Necrotizing Fasciitis Caused by Community-Associated Methicillin-ResistantStaphylococcus aureusin Los Angeles

    Authors: , , , , , , , , - New England Journal of Medicine 2005 cited by 1,053

  19. Carotenoid-Related Alteration of Cell Membrane Fluidity Impacts Staphylococcus aureus Susceptibility to Host Defense Peptides

    Authors: , , , , , , - Antimicrobial Agents and Chemotherapy 2010 cited by 214

  20. The Staphylococcus aureus Two-Component Regulatory System, GraRS, Senses and Confers Resistance to Selected Cationic Antimicrobial Peptides

    Authors: , , , , , , , - Infection and Immunity 2011 cited by 158

  21. Whole-Genome Analysis of a Daptomycin-Susceptible Enterococcus faecium Strain and Its Daptomycin-Resistant Variant Arising during Therapy

    Authors: , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2012 cited by 129

  22. A liaR Deletion Restores Susceptibility to Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis

    Authors: , , , , , , , , , , , , - The Journal of Infectious Diseases 2014 cited by 101

  23. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides

    Authors: , , , , , - Antimicrobial Agents and Chemotherapy 2015 cited by 97

  24. Persistent Bacteremia Due to Methicillin‐ResistantStaphylococcus aureusInfection Is Associated withagrDysfunction and Low‐Level In Vitro Resistance to Thrombin‐Induced Platelet Microbicidal Protein

    Authors: , , , , , , , , , , , , , - The Journal of Infectious Diseases 2004 cited by 350